TY - JOUR
T1 - Complement C1q-dependent excitatory and inhibitory synapse elimination by astrocytes and microglia in Alzheimer's disease mouse models
AU - Dejanovic, Borislav
AU - Wu, Tiffany
AU - Tsai, Ming-Chi
AU - Graykowski, David
AU - Gandham, Vineela D
AU - Rose, Christopher M
AU - Bakalarski, Corey E
AU - Ngu, Hai
AU - Wang, Yuanyuan
AU - Pandey, Shristi
AU - Rezzonico, Mitchell G
AU - Friedman, Brad A
AU - Edmonds, Rose
AU - De Mazière, Ann
AU - Rakosi-Schmidt, Raphael
AU - Singh, Tarjinder
AU - Klumperman, Judith
AU - Foreman, Oded
AU - Chang, Michael C
AU - Xie, Luke
AU - Sheng, Morgan
AU - Hanson, Jesse E
N1 - Publisher Copyright:
© 2022, The Author(s).
PY - 2022/9
Y1 - 2022/9
N2 - Microglia and complement can mediate neurodegeneration in Alzheimer's disease (AD). By integrative multi-omics analysis, here we show that astrocytic and microglial proteins are increased in Tau
P301S synapse fractions with age and in a C1q-dependent manner. In addition to microglia, we identified that astrocytes contribute substantially to synapse elimination in Tau
P301S hippocampi. Notably, we found relatively more excitatory synapse marker proteins in astrocytic lysosomes, whereas microglial lysosomes contained more inhibitory synapse material. C1q deletion reduced astrocyte-synapse association and decreased astrocytic and microglial synapses engulfment in Tau
P301S mice and rescued synapse density. Finally, in an AD mouse model that combines β-amyloid and Tau pathologies, deletion of the AD risk gene Trem2 impaired microglial phagocytosis of synapses, whereas astrocytes engulfed more inhibitory synapses around plaques. Together, our data reveal that astrocytes contact and eliminate synapses in a C1q-dependent manner and thereby contribute to pathological synapse loss and that astrocytic phagocytosis can compensate for microglial dysfunction.
AB - Microglia and complement can mediate neurodegeneration in Alzheimer's disease (AD). By integrative multi-omics analysis, here we show that astrocytic and microglial proteins are increased in Tau
P301S synapse fractions with age and in a C1q-dependent manner. In addition to microglia, we identified that astrocytes contribute substantially to synapse elimination in Tau
P301S hippocampi. Notably, we found relatively more excitatory synapse marker proteins in astrocytic lysosomes, whereas microglial lysosomes contained more inhibitory synapse material. C1q deletion reduced astrocyte-synapse association and decreased astrocytic and microglial synapses engulfment in Tau
P301S mice and rescued synapse density. Finally, in an AD mouse model that combines β-amyloid and Tau pathologies, deletion of the AD risk gene Trem2 impaired microglial phagocytosis of synapses, whereas astrocytes engulfed more inhibitory synapses around plaques. Together, our data reveal that astrocytes contact and eliminate synapses in a C1q-dependent manner and thereby contribute to pathological synapse loss and that astrocytic phagocytosis can compensate for microglial dysfunction.
KW - Alzheimer Disease/genetics
KW - Animals
KW - Astrocytes/metabolism
KW - Complement C1q/genetics
KW - Membrane Glycoproteins/metabolism
KW - Mice
KW - Microglia/metabolism
KW - Receptors, Immunologic/metabolism
KW - Synapses/metabolism
UR - http://www.scopus.com/inward/record.url?scp=85138436598&partnerID=8YFLogxK
U2 - 10.1038/s43587-022-00281-1
DO - 10.1038/s43587-022-00281-1
M3 - Article
C2 - 37118504
VL - 2
SP - 837
EP - 850
JO - Nature Aging
JF - Nature Aging
IS - 9
ER -